![Intrinsic Compounding on Twitter: "If you look beyond the other income in the results of BKT. Then core EBITDA margins have collapsed severely. Investor presentation includes the other income in EBITDA calculations. Intrinsic Compounding on Twitter: "If you look beyond the other income in the results of BKT. Then core EBITDA margins have collapsed severely. Investor presentation includes the other income in EBITDA calculations.](https://pbs.twimg.com/media/FZdU0EDUIAEJne5.jpg)
Intrinsic Compounding on Twitter: "If you look beyond the other income in the results of BKT. Then core EBITDA margins have collapsed severely. Investor presentation includes the other income in EBITDA calculations.
Biocon - #BioconQ2FY20: Net R&D expenses went up by 36% on higher spends across Small Molecules, Biosimilars & Novel development programs. EBITDA Margin was 27%, Core EBITDA Margin (net of licensing, impact
![Biocon Q2FY23 Revenue at Rs. 2,384 Cr., Up 23 percent; Core EBITDA at Rs. 816 Cr., Up 34 percent Gross R&D Spend at Rs. 252 Crore, Up 52 percent - Marksmen Daily - Biocon Q2FY23 Revenue at Rs. 2,384 Cr., Up 23 percent; Core EBITDA at Rs. 816 Cr., Up 34 percent Gross R&D Spend at Rs. 252 Crore, Up 52 percent - Marksmen Daily -](https://marksmendaily.com/wp-content/uploads/2022/11/22391_image-zSYjcm.jpeg)
Biocon Q2FY23 Revenue at Rs. 2,384 Cr., Up 23 percent; Core EBITDA at Rs. 816 Cr., Up 34 percent Gross R&D Spend at Rs. 252 Crore, Up 52 percent - Marksmen Daily -
![Rahul Mithal: Our focus is on growth of core EBITDA on a steady basis: Rahul Mithal - The Economic Times Rahul Mithal: Our focus is on growth of core EBITDA on a steady basis: Rahul Mithal - The Economic Times](https://img.etimg.com/thumb/width-640,height-480,imgsize-3652,resizemode-1,msid-96365393/markets/expert-view/our-focus-is-on-growth-of-core-ebitda-on-a-steady-basis-rahul-mithal/rahul-mithal-chairman-managing-director.jpg)
Rahul Mithal: Our focus is on growth of core EBITDA on a steady basis: Rahul Mithal - The Economic Times
Intrinsic Compounding on Twitter: "If you look beyond the other income in the results of BKT. Then core EBITDA margins have collapsed severely. Investor presentation includes the other income in EBITDA calculations.
![EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed | Business Wire EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed | Business Wire](https://mms.businesswire.com/media/20220831005650/en/1365653/5/euroAPI_Logo_RVB_digital.jpg)
EUROAPI: Solid Business and Financial Performance in H1-2022 - Net Sales and Core EBITDA Margin Guidance for 2022 Confirmed | Business Wire
![Leonardo: nel primo trimestre 2022 ricavi a 3 mld (+8%), EBITDA a 132 mln (+39%) - Il Giornale d'Italia Leonardo: nel primo trimestre 2022 ricavi a 3 mld (+8%), EBITDA a 132 mln (+39%) - Il Giornale d'Italia](https://www.ilgiornaleditalia.it/resizer/395/-1/true/2022_05_05/Imagoeconomica_1636519-1651766737491.jpg--alessandro_profumo.jpg?1651766740722)